BIP
IDXX icon

Blueprint Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Blueprint Investment Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-577
Closed -$290K – 128
2023
Q2 		$290K Buy
577
+40
+7% +$19.2K 0.1% 121
2023
Q1 		$269K Sell
537
-44
-8% -$21.1K 0.06% 191
2022
Q4 		$237K Buy
+581
New +$226K 0.05% 192
2022
Q1 		– Sell
-349
Closed -$230K – 229
2021
Q4 		$230K Buy
349
+30
+9% +$18.8K 0.06% 177
2021
Q3 		$198K Buy
+319
New +$214K 0.1% 136

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Blueprint Investment Partners's IDXX Position: Q3 2023 in Review

Blueprint Investment Partners sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 577 shares — an estimated $290K sold.

Blueprint Investment Partners first reported a position in IDXX in Q3 2021 and held it in 5 quarters. The position peaked at $290K in Q2 2023. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Blueprint Investment Partners reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
  • Blueprint Investment Partners sold 577 Idexx Laboratories shares in Q3 2023, an estimated $290K.
  • Blueprint Investment Partners first reported a position in Idexx Laboratories in Q3 2021 and held it in 5 quarters.
  • Blueprint Investment Partners's Idexx Laboratories position peaked at $290K in Q2 2023.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Blueprint Investment Partners's 13F filing for Q3 2023, filed 15 Nov 2023.